OTC Markets OTCPK - Delayed Quote USD

OpGen, Inc. (OPGN)

Compare
1.8100 -0.1800 (-9.05%)
At close: November 21 at 12:34 PM EST

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Dr. Oliver Schacht Ph.D. Executive VP of Corporate Development 353.48k -- 1971
Mr. Honjian Tan CEO & Chairman -- -- 1990

OpGen, Inc.

9717 Key West Avenue
Suite 100
Rockville, MD 20850
United States
240 813 1260 https://www.opgen.com
Sector:?
Healthcare
Industry:?
Medical Devices

Description

OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company's products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. OpGen, Inc. was incorporated in 2001 and is headquartered in Rockville, Maryland.

Corporate Governance

OpGen, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 15, 2024 at 9:00 PM UTC

OpGen, Inc. Earnings Date

Recent Events

November 15, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

November 14, 2024 at 12:00 AM UTC

NT 10-Q: Periodic Financial Reports

October 9, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 22, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 19, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

August 15, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 14, 2024 at 12:00 AM UTC

NT 10-Q: Periodic Financial Reports

August 2, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 8, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

June 11, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers